This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Chronic Sinusitis
and you are
over 18
years old
-
The phase for this study is not defined.
Show me locations

The purpose

This study allows continued access to the Sinexus Intranasal Splint while a marketing application is being prepared. This study will generate additional performance, reimbursement and safety data for the steroid-eluting Sinexus Intranasal Splint when used following Functional Endoscopic Sinus Surgery (FESS) in patients with chronic sinusitis (CS).

Provided treatments

  • Device: Steroid-Eluting Sinexus Intranasal Splint
Tris trial is registered with FDA with number: NCT00912405. The sponsor of the trial is Intersect ENT and it is looking for 50 volunteers for the current phase.
Official trial title:
A Clinical Evaluation of the Steroid-Eluting Sinexus Intranasal Splint When Used Following Functional Endoscopic Sinus Surgery in Patients With Chronic Sinusitis